Skip to main content
    V

    Vanda Pharmaceuticals Inc (VNDA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.81
    +0.00 (+0.00%)

    Market Cap: $230.39M

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Vanda Pharmaceuticals Inc (VNDA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Vanda Pharmaceuticals (VNDA) has a latest price of $3.81 on Nov 17, 2026, 61.7% below its 52-week high of $9.94. Its price fell 12.4% over the past 12 months. The month-end price fell 74.5% over the 10 years through Oct 2026, a compound annual decline of 12.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $27.13 in Jan 2019 and its lowest $3.60 in Jan 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart VNDA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VNDA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 31.6%, and over 6 months it fell 36.4%. The month-end price fell 13.5% over the 3 years through Oct 2026, a compound annual decline of 4.7%.

    PeriodChange
    1 month-6.8%
    3 months-31.6%
    6 months-36.4%
    12 months-12.4%
    12 months, with dividends-12.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-13.5%-4.7%
    5 years-77.9%-26.0%
    10 years-74.5%-12.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 84.1%, and its weakest was 2022, when it fell 52.9%.

    YearCloseChange
    2026 through Oct 2026$3.79-57.0%
    2025$8.82+84.1%
    2024$4.79+13.5%
    2023$4.22-42.9%
    2022$7.39-52.9%
    2021$15.69+19.4%
    2020$13.14-19.9%
    2019$16.41-37.2%
    2018$26.13+71.9%
    2017$15.20-4.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 14.1% below its 50-day average of $4.43 and 36.3% below its 200-day average of $5.98.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$3.81
    52-week high$9.94-61.7%
    52-week low$3.57+6.7%
    50-day average$4.43-14.1%
    200-day average$5.98-36.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 62.5%.

    MeasureValue
    1-year beta1.05
    Largest fall, 1 year-62.4%
    Largest fall, 3 years-62.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About VNDA

    What is VNDA's 1-year price change?

    Vanda Pharmaceuticals's price fell 12.4% over the past 12 months. With dividends included, the 12-month total return was -12.4%.

    What is VNDA's 5-year price change?

    Vanda Pharmaceuticals's month-end price fell 77.9% over the 5 years through Oct 2026, a compound annual decline of 26.0%. These figures leave out dividends.

    What is VNDA's 52-week high and low?

    Vanda Pharmaceuticals's 52-week high is $9.94 and its 52-week low is $3.57. Its latest price of $3.81 on Nov 17, 2026 is 61.7% below the high.

    What is VNDA's beta?

    Vanda Pharmaceuticals's 1-year beta against the S&P 500 is 1.05, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 62.4%.

    Is the VNDA chart free?

    Yes. Advanced Charting for VNDA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.